FACTOR TIME FOR ACTIVE IMMUNOTHERAPY AFTER CYTOREDUCTIVE CHEMOTHERAPY

被引：13

作者：

AMIEL, JL ^{[1
]}

BERARDET, M ^{[1
]}

机构：

[1] HOP PAUL-BROUSSE,INST CANCEROL & IMMUNOGENET,14-16 AVE PAUL-VAILLANT COUTURIER,94.800-VILLEJUIF,FRANCE

来源：

关键词：

D O I：

10.1016/0014-2964(74)90057-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：89 / 91

页数：3

共 13 条

[1] ATTEMPTS TO PREVENT ACQUIRED IMMUNOLOGICAL INSUFFICIENCES IN MICE BY BACILLUS CALMETTE-GUERIN
AMIEL, JL
BERARDET, M
[J]. EXPERIENTIA, 1971, 27 (08): : 941 - &
[2] AMIEL JL, 1969, REV FR ETUD CLIN BIO, V14, P912
[3] AMIEL JL, 1964, REV FR ETUD CLIN BIO, V9, P636
[4] AMIEL JL, 1969, REV FR ETUD CLIN BIO, V14, P685
[5] EXPERIMENTAL MODEL OF ACTIVE IMMUNOTHERAPY PRECEDED BY CYTOREDUCTIVE CHEMOTHERAPY
AMIEL, JL
BERARDET, M
[J]. EUROPEAN JOURNAL OF CANCER, 1970, 6 (06) : 557 - &
[6] AMIEL JL, 1967, REV FR ETUD CLIN BIO, V12, P912
[7] AMIEL JL, 1967, EUR J CANCER, V3, P42
[8] ACTIVE IMMUNOTHERAPY WITH CORYNEBACTERIUM PARVUM AND CHEMOTHERAPY IN MURINE FIBROSARCOMAS
CURRIE, GA
BAGSHAWE, KD
[J]. BRITISH MEDICAL JOURNAL, 1970, 1 (5695) : 541 - &
[9] MATHE G, 1973, Experimental Hematology (Charlottesville), V1, P110
[10] MATHE G, 1971, EUROP J CLIN BIOL RE, V16, P216